Protective effect of tolvaptan against cyclophosphamide‐induced nephrotoxicity in rat models
出版年份 2020 全文链接
标题
Protective effect of tolvaptan against cyclophosphamide‐induced nephrotoxicity in rat models
作者
关键词
-
出版物
Pharmacology Research & Perspectives
Volume 8, Issue 5, Pages -
出版商
Wiley
发表日期
2020-09-30
DOI
10.1002/prp2.659
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Renoprotective effect of tolvaptan in patients with new‐onset acute heart failure
- (2020) Hiromi Kin et al. ESC Heart Failure
- Tolvaptan activates the Nrf2/HO-1 antioxidant pathway through PERK phosphorylation
- (2019) Tamami Fujiki et al. Scientific Reports
- Bone marrow-derived versus adipose-derived stem cells in wound healing: value and route of administration
- (2018) Basma Emad Aboulhoda et al. CELL AND TISSUE RESEARCH
- Naringin protects against cyclophosphamide-induced hepatotoxicity and nephrotoxicity through modulation of oxidative stress, inflammation, apoptosis, autophagy, and DNA damage
- (2018) Cuneyt Caglayan et al. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
- Renoprotective effects of tolvaptan in hypertensive heart failure rats depend on renal decongestion
- (2018) Hiroki Chiba et al. HYPERTENSION RESEARCH
- Effectiveness of tolvaptan monotherapy and low-dose furosemide/tolvaptan combination therapy for hepatoprotection and diuresis in a rat cirrhotic model
- (2017) Norikazu Tanabe et al. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
- Cancer and the kidney: dangereoux liasons or price paid for the progress in medicine?
- (2017) Jolanta Małyszko et al. Oncotarget
- Rutin ameliorates cyclophosphamide induced oxidative stress and inflammation in Wistar rats: Role of NFκB/MAPK pathway
- (2015) Sana Nafees et al. CHEMICO-BIOLOGICAL INTERACTIONS
- 18β-Glycyrrhetinic acid exerts protective effects against cyclophosphamide-induced hepatotoxicity: potential role of PPARγ and Nrf2 upregulation
- (2015) Ayman M. Mahmoud et al. Genes and Nutrition
- Urinary excretion of the water channel aquaporin 2 correlated with the pharmacological effect of tolvaptan in cirrhotic patients with ascites
- (2015) Hiroyuki Nakanishi et al. JOURNAL OF GASTROENTEROLOGY
- 18β-Glycyrrhetinic acid exerts protective effects against cyclophosphamide-induced hepatotoxicity: potential role of PPARγ and Nrf2 upregulation
- (2015) Ayman M. Mahmoud et al. Genes and Nutrition
- Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis
- (2014) Eman M. Mantawy et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Berberine mitigates cyclophosphamide-induced hepatotoxicity by modulating antioxidant status and inflammatory cytokines
- (2014) Mousa O. Germoush et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH)
- (2014) A. Peri et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Tolvaptan for the treatment of liver cirrhosis oedema
- (2014) Isao Sakaida Expert Review of Gastroenterology & Hepatology
- Intervention in cyclophosphamide induced oxidative stress and DNA damage by a flavonyl-thiazolidinedione based organoselenocyanate and evaluation of its efficacy during adjuvant therapy in tumor bearing mice
- (2013) Somnath Singha Roy et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Amelioration of cyclophosphamide-induced hepatotoxicity by the root extract of Decalepis hamiltonii in mice
- (2013) Mahsa Zarei et al. FOOD AND CHEMICAL TOXICOLOGY
- Mechanism for the protective effect of diallyl disulfide against cyclophosphamide acute urotoxicity in rats
- (2013) Sung-Hwan Kim et al. FOOD AND CHEMICAL TOXICOLOGY
- Renoprotective Effect of Vasopressin V2 Receptor Antagonist Tolvaptan in Dahl Rats With End-Stage Heart Failure
- (2013) Mayuko Ishikawa et al. International Heart Journal
- Chronic Administration of Oral Vasopressin Type 2 Receptor Antagonist Tolvaptan Exerts Both Myocardial and Renal Protective Effects in Rats With Hypertensive Heart Failure
- (2012) Hanako Morooka et al. Circulation-Heart Failure
- Cyclophosphamide-induced nephrotoxicity, genotoxicity, and damage in kidney genomic DNA of Swiss albino mice: the protective effect of Ellagic acid
- (2012) Muneeb U. Rehman et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The Protective Effects of Spirulina in Cyclophosphamide Induced Nephrotoxicity and Urotoxicity in Rats
- (2012) Orhun Sinanoglu et al. UROLOGY
- Hyponatremia and antidiuresis syndrome
- (2011) Marie-Christine Vantyghem et al. ANNALES D ENDOCRINOLOGIE
- Efficacy and Safety of Tolvaptan in Heart Failure Patients with Sustained Volume Overload despite the Use of Conventional Diuretics: A Phase III Open-Label Study
- (2011) Masatake Fukunami et al. CARDIOVASCULAR DRUGS AND THERAPY
- The effects of oral glutamine on cyclophosphamide-induced nephrotoxicity in rats
- (2010) Premila Abraham et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- Incidence of hyponatremia in children with gastroenteritis treated with hypotonic intravenous fluids
- (2010) Mina Hanna et al. PEDIATRIC NEPHROLOGY
- Uroprotective Effects of Curcumin in Cyclophosphamide-Induced Haemorrhagic Cystitis Paradigm
- (2009) Hossam M. M. Arafa BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Urological implications of cyclophosphamide and ifosfamide
- (2008) Malcolm Lawson et al. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started